FNDC5 and breast fibrocystic disease: In our study recruiting patients with benign diseases of the breast as well as cancer patients that had received neoadjuvant chemotherapy, we found significantly higher serum irisin levels in both benign and newly diagnosed breast cancer subjects compared to healthy individuals after adjusting for potential covariates and a positive association with tumor behavior.